Status: Recruiting
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.
Participants needed: 1,148
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: National Institute of Cardiovascular Diseases, PakistanUpdated: Apr 22, 2026Locations: 2
Eligibility criteria
All patients with acute STEMI undergoing primary PCI [+1]
STEMI patients with cardiogenic shock at presentation [+3]